Clinical trial
Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis
NCT05661266 is registered in ClinicalTrials.gov with Innodem Neurosciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis
- Lead sponsor
- Innodem Neurosciences
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 16, 2023
- Completion date
- April 30, 2025
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.